Clinical Oncology
Volume 22, Issue 2 , Pages 107-113 , March 2010

Factors Predicting Outcome for Advanced Gastroesophageal Cancer in Elderly Patients Receiving Palliative Chemotherapy

  • S.R. Lord

      Affiliations

    • St James University Hospital, St James Institute of Oncology, Level 4, Bexley Wing, Beckett Street, Leeds LS9 7TF, UK
    • Corresponding Author InformationAuthor for correspondence. S.R. Lord, c/o Mrs G. Wagner-Adair, Level 4, Bexley Wing, St James University Hospital, Beckett Street, Leads LS9 7TF, UK. Tel: +44-113-2068586; Fax: +44-113-2068474.
    • ,
  • P.S. Hall

      Affiliations

    • University of Leeds, Leeds, UK
    • ,
  • P. McShane

      Affiliations

    • University of Leeds, Leeds, UK
    • ,
  • J. Brown

      Affiliations

    • University of Leeds, Leeds, UK
    • ,
  • M.T. Seymour

      Affiliations

    • St James University Hospital, St James Institute of Oncology, Level 4, Bexley Wing, Beckett Street, Leeds LS9 7TF, UK

Received 6 September 2009 ,Revised 3 December 2009 ,Accepted 7 December 2009.

References 

  1. Cancer Research UK. CancerStats. Available from: http://info.cancerresearchuk.org/cancerstats. Accessed June 2009.
  2. Kocher HM, Linklater K, Patel S, Ellul JP. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg. 2001;88:1249–1257
  3. Scartozzi M, Galizia E, Verdecchia L, et al. Chemotherapy for advanced gastric cancer: across the years for a standard of care. Expert Opin Pharmacother. 2007;8:797–808
  4. Janunger KG, Hafstrom L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol. 2001;40:309–326
  5. Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358:36–46
  6. Moynihan T, Hansen R, Anderson T, et al. Continuous 5-fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol. 1988;11:461–464
  7. Kok TC, van der Gaast A, Splinter TA. 5-fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Rotterdam Esophageal Tumor Study Group. Ann Oncol. 1996;7:533–534
  8. Sakamoto J, Chin K, Kondo K, et al. Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer. Anticancer Drugs. 2006;17:231–236
  9. Hong YS, Song SY, Lee SI, et al. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer. Ann Oncol. 2004;15:1344–1347
  10. Levi F, Lucchini F, Negri E, et al. Mortality from major cancer sites in the European Union, 1955–1998. Ann Oncol. 2003;14:490–495
  11. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766–2792
  12. Polee MB, Hop WC, Kok TC, et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer. 2003;89:2045–2050
  13. Chau I, Norman AR, Cunningham D, et al. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol. 2004;22:2395–2403
  14. Popescu RA, Norman A, Ross PJ, et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol. 1999;17:2412–2418
  15. Meta-Analysis Group in Cancer . Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Cancer J Clin Oncol. 1998;16:3537–3541
  16. Stein BN, Petrelli NJ, Douglass HO, et al. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial. Cancer. 1995;75:11–17
  17. Accessed UK: National Cancer Intelligence Network; February 2009;http://www.ncis.org.uk
  18. Trumper M, Ross PJ, Cunningham D, et al. Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: a pooled analysis of three clinical trials. Eur J Cancer. 2006;42:827–834
  19. Folprecht G, Cunningham D, Ross P, et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol. 2004;15:1330–1338
  20. Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24:2903–2909
  21. Crosby T. Scottish Intercollegiate Guidelines Network (SIGN) 87–The management of oesophageal and gastric cancer. Clin Oncol (R Coll Radiol). 2008;20:528–529
  22. Alderson D. Scottish Intercollegiate Guidelines Network (SIGN) 87–The management of oesophageal and gastric cancer. Clin Oncol (R Coll Radiol). 2008;20:530–531

PII: S0936-6555(09)00407-5

doi: 10.1016/j.clon.2009.12.001

Clinical Oncology
Volume 22, Issue 2 , Pages 107-113 , March 2010

Article Tools

* Image Usage & Resolution